Source: European Medicines Agency (EU) Revision Year: 2018 Publisher: Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
TRAVATAN 40 micrograms/mL eye drops, solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. (eye drops) Clear, colourless solution. |
Each mL of solution contains 40 micrograms of travoprost.
Excipient(s) with known effect: Each mL of solution contains polyquaternium-1 (POLYQUAD) 10 microgram, propylene glycol 7.5 mg, polyoxyethylene hydrogenated castor oil 40 (HCO-40) 2 mg (see section 4.4.).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Travoprost |
Travoprost, a prostaglandin F2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways. |
| List of Excipients |
|---|
|
Polyquaternium-1 |
4 mL oval Polypropylene (PP) or Low Density Polyethylene (LDPE) bottle and PP or LDPE dispensing plug with a PP screw cap, presented in an overwrap. Each 4 mL bottle will contain 2.5 mL of solution.
Cartons containing 1 or 3 bottles.
Not all pack sizes may be marketed.
Novartis Europharm Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
EU/1/01/199/001-004
Date of first authorisation: 27 November 2001
Date of latest renewal: 06 October 2006
| Drug | Countries | |
|---|---|---|
| TRAVATAN | Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
